Finance

Lists
Why is 002907 down 2.72%?
Dive Deeper
002907:SHE
Chongqing Pharscin Pharmaceutical Co Ltd
CNÂ¥12.15
-2.72%
(-0.34) 1D
Nov 18, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002907...
Open
CNÂ¥12.58
High
CNÂ¥12.68
Low
CNÂ¥12.06
Mkt. cap
5.22B
Avg. vol.
10.68M
Volume
4.11M
Dividend
0.62%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 4, 2026
P/E ratio
54.07
52-wk high
CNÂ¥18.47
52-wk low
CNÂ¥11.42
EPS
CNÂ¥0.22
Shares outstanding
417.60M
No. of employees
1K
Open
CNÂ¥12.58
High
CNÂ¥12.68
Low
CNÂ¥12.06
Mkt. cap
5.22B
Avg. vol.
10.68M
Volume
4.11M
Dividend
0.62%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 4, 2026
P/E ratio
54.07
52-wk high
CNÂ¥18.47
52-wk low
CNÂ¥11.42
EPS
CNÂ¥0.22
Shares outstanding
417.60M
No. of employees
1K
News stories
From web sources and news partners
About Chongqing Pharscin Pharmaceutical Co Ltd
CEO-
Employees1.44K
FoundedNov 4, 1996
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
201.23M
211.85M
201.70M
235.51M
Cost of goods sold
92.46M
84.88M
84.18M
114.22M
Cost of revenue
92.46M
84.88M
84.18M
114.22M
Research and development expenses
30.52M
19.49M
13.73M
18.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82.65M
73.76M
70.71M
64.59M
Operating expense
117.57M
96.54M
90.78M
86.71M
Total operating expenses
210.02M
181.41M
174.96M
200.93M
Operating income
-8.79M
30.43M
26.74M
34.58M
Other non operating income
15.80M
674.52K
-711.55K
-571.42K
EBT including unusual items
-12.09M
37.60M
30.20M
47.41M
EBT excluding unusual items
-1.01M
34.28M
27.44M
34.59M
Income tax expense
618.10K
8.69M
3.15M
11.69M
Effective tax rate
-5.11%
23.12%
10.43%
24.67%
Other operating expenses
5.32M
1.93M
4.13M
2.02M
Net income
-7.37M
32.79M
30.19M
38.22M
Net profit margin
-3.66%
15.48%
14.97%
16.23%
Earnings per share
-
-
-
-
Interest and investment income
150.51K
3.24M
1.71M
1.13M
Interest expense
-8.19M
-70.53K
-292.83K
-547.08K
Net interest expenses
-8.03M
3.17M
1.41M
578.94K
Depreciation and amortization charges
-
-
-
-
EBITDA
12.63M
51.86M
50.50M
56.01M
Gain or loss from assets sale
-10.25M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps